Program Details
- Intended Audience: Pharmacists interested associated with the Tampa General Residency Program
- Universal Activity Number: 0012-0000-24-010-L01-P
- Contact Hours: 1.0 General hours of ACPE continuing education for pharmacists
- Program Fees: Complimentary for pharmacists associated with the Tampa General Residency Program
- UAN Release Date: 07/01/2024
- UAN Expiration Date: 06/30/2025
- Activity Type: Knowledge
- Program Support: No outside financial support was provided.
Objectives
At the completion of this activity, the participant will be able to:
- Review relevant epidemiology, pathophysiology, and etiology of disease states encountered by pharmacists at a tertiary care health system.
- Discuss the pharmacology, pharmacokinetics, and literature of pertinent medications used as standard of care for common disease states seen in the tertiary care setting.
- Summarize published literature regarding an area of clinical controversy or developing research for common disease states encountered in a tertiary care health system.
- Compare and contrast the presented evidence with current practices at the tertiary care health system and identify opportunities for changes to practice based on relevant or new evidence.
Requirements for Successful Course Completion
Attendance at the RSS Grand Rounds presentation and submit an evaluation within 15 days of the presentation.
Schedule of Activities
| Title | Presenter | Presentation Date |
|---|---|---|
| Alternative Maintenance Immunosuppression | Elise Heiman Pharm.D. | 07/26/2022 |
| Don’t be a “Harmacist”: Fluid Stewardship Editio | Brittany Tyree Pharm.D. | 08/09/2022 |
| Continuous Glucose Monitoring | Chandler Wilson Pharm.D. | 8/23/2022 |
| Don’t Get A-HEAD of Yourself: Andexanet alfa Versus 4 Factor Prothrombin Complex Concentrate for Factor Xa Inhibitor-Related Intracranial Hemorrhage | Heather Schucker Pharm.D. | 9/27/2022 |
| Phenobarbital in Alcohol Withdrawal | Jaleesa DeKilder Pharm.D. | 10/11/2022 |
| What is One to Do(ac)? Preventing Stroke in Patients with Hemophilia and Atrial Fibrillation | Tasha Butler Pharm.D. | 10/25/2022 |
| Anticoagulation in Solid Organ Transplant | Aysia Johnson Pharm.D. | 11/8/2022 |
| You’re Not The Only One Who’s Hangry: Nutrition in Critically Ill Patients | Austin Burnette Pharm.D. | 11/22/2022 |
| Review of Stem Cell Transplantation & Graft-Versus-Host Disease Management | Kylie Paul Pharm .D. | 1/10/2023 |
| The Organ(ism) You Didn’t Know You Were Getting: Donor-Derived Infections in Solid Organ Transplant | Lizbeth Haker Pharm .D. | 1/24/2023 |
| Feeling Rusty? Cleaning Up Iron Controversies | Jaleesa DeKilder Pharm .D. | 2/14/2023 |
| Symptom Free? Let it Be! When to Treat Asymptomatic Bacteriuria | Tasha Butler Pharm .D. | 2/28/2023 |
| Let’s Get Serious About C. auris | Aysia Johnson Pharm.D. | 3/14/2023 |
| Still Alive But I’m Barely Breathing: RSI Controversies and Considerations | Austin Burnette Pharm .D. | 3/28/2023 |
| One CYP at a Time: CYP2C19 and P2Y12 Inhibitor Selection in Stroke | Kylie Paul Pharm.D. | 4/11/2023 |
| PGY1 Research Grand Rounds (Lizbeth Haker, Aysia Johnson, Jaleesa DeKilder) | 4/25/2023 |
|
| PGY1 Research Grand Rounds (Kylie Paul, Austin Burnette, Tasha Butler) | 5/9/2023 |
|
| Lizbeth Haker Pharm.D. | 5/23/2023 |
|
| PGY2 Research Grand Rounds (Elise Heiman, Brittany Tyree, Chandler Wilson, Heather Schucker) | 6/13/2023 |
|
| Breaking the Mold: Emerging Fungal Infections in Solid Organ Transplant Recipients. | Elise Heiman Pharm .D. | 6/14/2023 |
| Blast from the RAAS: The Role of RAAS in Vasodilatory Shock | Nicolas Tran Pharm.D. | 07/25/2023 |
| Can't Live, Can't Breath Without AIR Updates in Asthma Management | Tasha Butler Pharm.D. | 08/18/2023 |
| Take some PICS: Considerations and Proposed Treatments for a Novel Disease State | Austin Burnette Pharm.D. | 09/5/2023 |
| More Morphine, More Problems? Morphine in Acute Coronary Syndromes | Emily Montgomery Pharm.D. | 9/12/2023 |
| And At Last, I “C” The Light Organ Transplantation of Hepatitis C Virus (HCV) Positive Donors to HCV Negative Recipients | Cody Tong Pharm.D. | 9/26/2023 |
| Corticosteroids in Septic Shock: Who, When, and How to Treat? | Luke Posgai Pharm.D. | 10/10/2023 |
| Immune Checkpoint Inhibitors and Immune-Related Adverse Events | Alexa Kupper Pharm.D. | 10/24/2023 |
| Driving the Future of Cancer Treatment: Overview of CAR T-Cell Therapy | Haneen Ottallah Pharm.D. | 10/31/2023 |
| “Triple Threat?” Updates in the use of Triple Therapy After Percutaneous Coronary Intervention | Shannon Komisarchik Pharm.D. | 11/7/2023 |
| The skinny on weight loss: updates inobesity management | Savannah Nelson Pharm.D. | 11/14/2023 |
| Seize the Moment: Updates in the Treatment of Refractory Status Epilepticus | Stephanie Toole Pharm.D. | 11/28/2023 |
| What's New in Code Blue: Updates in Cardiac Arrest | Luke Posgai Pharm.D. | 1/9/2024 |
| Let’s Make the Switch: Oral Antibiotics in Systemic Infections | Alexa Kupper Pharm.D. | 1/23/2024 |
| "Assistance with Resistance: IDSA 2023 Guidance on the Treatment of Antimicrobial Resistant Gram (-) Infections" | Karl Ramos Pharm.D. | 1/24/2024 |
| Management of hyperglycemic crises: keep calm and put insulin on | Savannah Nelson Pharm.D. | 2/6/2024 |
| A Wake-Up Call onPharmacotherapy Considerations in Sleep Disorders | Shannon Komisarchik Pharm.D. | 2/27/2024 |
| Going Viral: Novel Therapies in Cytomegalovirus Management in Solid Organ Transplant | Haneen Ottallah Pharm.D. | 3/26/2024 |
| I've GAHT to Clear This Up: Gender Affirming Hormone Therapy and Associated Pharmacologic Considerations | Stephanie Toole Pharm.D. | 4/9/2024 |
| Gone with the Weight:Weight Loss Pharmacotherapy in Solid Organ Transplant | Minh Tong Pharm.D. | 5/20/2024 |
| Who’s Afraid of Little Old Me? Gram-negative Resistance & Pharmacotherapy | Melissa O'Neal Pharm.D. | 7/23/2024 |
| Caution! Baby on Board:Management of the Critically Ill Pregnant Patient | Luke Posgai Pharm. D. | 8/13/2024 |
| Savannah Nelson Pharm.D. | 8/27/2024 |
|
| Hannah Chapman | 9/10/2024 | |
| Natt Patimavirujh | 9/24/2024 | |
| Jean Kim | 10/1/2024 | |
| Jillian Walker | 10/22/2024 | |
| Kaitlyn Kenyon | 10/29/2024 | |
| Alexander Coughlin | 11/5/2024 | |
| 11/12/2024 | ||
| Isabel Matt | 12/3/2024 | |
| 2/25/2024 | ||
| 3/11/2025 | ||
| 3/25/2025 | ||
| 4/8/2025 | ||
| 4/22/2025 | ||
| 4/29/2025 | ||
| 6/10/2025 |
Disclosure Statement
No other speaker, reviewer, or planning committee member in a position to control content has any financial relationships to disclose.
Additional Resources
Please review the resources below before registering for the course.
The University of Florida College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.